Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call | STIM Stock News

3 days ago

Neuronetics (STIM, Financial) to release Q2 2025 financial results on August 5, 2025.
A live webcast and conference call scheduled for 8:30 a.m. Eastern Time on the same day.
Neuronetics specializes in non-invasive treatments for neurohealth disorders.

Neuronetics, Inc. (STIM), a leading medical technology company in the field of neurohealth treatment solutions, has announced that it will release its second quarter 2025 financial and operating results before the market opens on Tuesday, August 5, 2025. The announcement will be followed by a live webcast and a conference call at 8:30 a.m. Eastern Time to discuss the results in detail.

Participants can access the live webcast through the provided link, and telephone listeners are encouraged to register and join at least 10 minutes before the event begins. The company aims to provide insights into its performance and future outlook during the call.

Neuronetics is renowned for its NeuroStar Advanced Therapy, a non-drug and non-invasive treatment for mental health conditions, particularly major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The company is dedicated to advancing mental health treatments through innovative technology and research.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.